Steris

STE · NYSE · USD

$208.54Change from previous close: −0.38%Absolute change: −$0.80

Close · October 2, 2026

At a glance

Revenue growth
+8.73%
FY to Mar 2026 vs FY to Mar 2025
Net income growth
+27.27%
FY to Mar 2026 vs FY to Mar 2025
Net margin
13.2%
FY to Mar 2025: 11.3%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Income statement · Annual
ItemFY to Mar 2026FY to Mar 2025FY to Mar 2024FY to Mar 2023FY to Mar 2022
Total revenue5,9365,4605,1394,536—
Cost of revenue3,3093,0572,9212,556—
Gross profit2,6272,4032,2181,981—
Selling, general and administrative1,4081,3341,2521,091—
Research and development11310810498.5—
Operating income1,106961862792—
EBIT1,108883847791—
EBITDA1,5951,3591,4121,344—
Interest expense60.786.3144111—
Pre-tax income1,047796703680—
Income tax262185150124—
Net income782615378107—
Net income to common shareholders782615378107—
Basic EPS7.976.243.831.07—
Diluted EPS7.936.203.811.07—
Average shares (basic)98.298.698.899.7—
Average shares (diluted)98.799.199.4100—